HomeCompareEAPIF vs DVY

EAPIF vs DVY: Dividend Comparison 2026

EAPIF yields 157.48% · DVY yields 3.50%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EAPIF wins by $36.0K in total portfolio value
10 years
EAPIF
EAPIF
● Live price
157.48%
Share price
$1.27
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$61.1K
Annual income
$47.71
Full EAPIF calculator →
DVY
DVY
● Live price
3.50%
Share price
$150.03
Annual div
$5.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$437.78
Full DVY calculator →

Portfolio growth — EAPIF vs DVY

📍 EAPIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEAPIFDVY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EAPIF + DVY cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EAPIF pays
DVY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EAPIF
Annual income on $10K today (after 15% tax)
$13,385.83/yr
After 10yr DRIP, annual income (after tax)
$40.55/yr
DVY
Annual income on $10K today (after 15% tax)
$297.17/yr
After 10yr DRIP, annual income (after tax)
$372.11/yr
At 15% tax rate, DVY beats the other by $331.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EAPIF + DVY for your $10,000?

EAPIF: 50%DVY: 50%
100% DVY50/50100% EAPIF
Portfolio after 10yr
$43.1K
Annual income
$242.74/yr
Blended yield
0.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on DVY right now

EAPIF
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
1.7
Piotroski
6/9
DVY
No analyst data
Altman Z
307.5
Piotroski
1/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EAPIF buys
0
DVY buys
0
No recent congressional trades found for EAPIF or DVY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEAPIFDVY
Forward yield157.48%3.50%
Annual dividend / share$2.00$5.25
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$61.1K$25.1K
Annual income after 10y$47.71$437.78
Total dividends collected$24.8K$4.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: EAPIF vs DVY ($10,000, DRIP)

YearEAPIF PortfolioEAPIF Income/yrDVY PortfolioDVY Income/yrGap
1← crossover$18,574$7,874.02$11,050$349.62+$7.5KEAPIF
2$26,708$6,834.21$12,184$361.04+$14.5KEAPIF
3$33,170$4,592.16$13,409$372.07+$19.8KEAPIF
4$38,157$2,665.03$14,730$382.68+$23.4KEAPIF
5$42,261$1,432.57$16,154$392.89+$26.1KEAPIF
6$45,960$741.42$17,688$402.69+$28.3KEAPIF
7$49,554$376.79$19,338$412.07+$30.2KEAPIF
8$53,213$189.84$21,113$421.04+$32.1KEAPIF
9$57,033$95.26$23,020$429.61+$34.0KEAPIF
10$61,073$47.71$25,070$437.78+$36.0KEAPIF

EAPIF vs DVY: Complete Analysis 2026

EAPIFStock

Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company was incorporated in 2021 and is based in Paris, France.

Full EAPIF Calculator →

DVYETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →
📬

Get this EAPIF vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EAPIF vs SCHDEAPIF vs JEPIEAPIF vs OEAPIF vs KOEAPIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.